SEC Form 4 · accession 0000899243-19-002708
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
E. Brendan Magrab
Director
Period of report
Feb 3, 2019
Accepted (ET)
Feb 5, 2019 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $0.076 | Feb 3, 2019 | A | 986,842 | A | Feb 3, 2020 | Feb 3, 2029 | Common Stock | 986,842 | 986,842 | D |